European Journal of Internal Medicine
Volume 20, Issue 3 , Pages 261-267 , May 2009

Progressive multifocal leukoencephalopathy, a review and an extended report of five patients with different immune compromised states

  • Jelle L. Epker

      Affiliations

    • Erasmus Medical Centre, Department of Intensive Care Medicine, The Netherlands
    • Corresponding Author InformationCorresponding author. Erasmus Medical Centre, Department of Intensive Care Medicine, 6 zuid, Postbus 2040, 3000 CA Rotterdam, The Netherlands. Tel.:+31 6 44460607; fax: +31 10 7042874.
    • ,
  • Paula van Biezen

      Affiliations

    • Erasmus Medical Centre, Department of Internal Medicine and Infectious Diseases, The Netherlands
    • ,
  • Paul L.A. van Daele

      Affiliations

    • Erasmus Medical Centre, Department of Internal Medicine and Immunology, The Netherlands
    • ,
  • Teun van Gelder

      Affiliations

    • Erasmus Medical Centre, Departments of Internal Medicine and Hospital Pharmacy, The Netherlands
    • ,
  • Ann Vossen

      Affiliations

    • Leiden University Medical Centre, Department of Medical Microbiology, The Netherlands
    • ,
  • Jan L.C.M. van Saase

      Affiliations

    • Erasmus Medical Centre, Departments of Internal Medicine and Nephrology, The Netherlands

Received 4 February 2008 ,Revised 19 May 2008 ,Accepted 7 July 2008.

References 

  1. Astrom KE, Mancall EL, Richardson EPJ. Progressive multifocal leuko-encephalopathy: a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain. 1958;81:93–111
  2. Narayan O, Penney JB, Johnson RT, Herndon RM, Weiner LP. Etiology of progressive multifocal leukoencephalopathy. Identification of papovavirus. N Engl J Med. 1973;289:1278–1282
  3. Padgett BL, Walker DL. Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J Infect Dis. 1973;127:467–470
  4. Demeter LM. JC,BK, and other polyomaviruses: progressive multifocal leukencephalopathy. In: Mandell's principles and practice of infectious diseases. vol. 2:New York: Churchill Livingstone; 1995;p. 1400–1406
  5. Polo C, Perez JL, Mielnichuck A, Fedele CG, Niubo J, Tenorio A. Prevalence and patterns of polyomavirus urinary excretion in immunocompetent adults and children. Clin Microbiol Infect. 2004;10:640–644
  6. Jeong BH, Lee KH, Choi EK, Kim K, Kim YS. Genotyping of the JC virus in urine samples of healthy Korean individuals. J Med Virol. 2004;72:281–289
  7. Sacktor N. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirology. 2002;8(Suppl 2):115–121
  8. Philippeau F, Honnorat J, Nighoghossian N, Getenet JC, Gray F, Kopp N, et al. JC virus infection and lympho-plasmocytic infiltration of the central nervous system revealed by a cerebellar syndrome]. Rev Neurol (Paris). 1999;155:961–965
  9. Ng C, Slavin MA, Seymour JF. Progressive multifocal leukoencephalopathy complicating Waldenstrom's macroglobulinaemia. Leuk Lymphoma. 2003;44:1819–1821
  10. Tubridy N, Wells C, Lewis D, Schon F. Unsuccessful treatment with cidofovir and cytarabine in progressive multifocal leukoencephalopathy associated with dermatomyositis. J R Soc Med. 2000;93:374–375
  11. Gentile S, Sacerdote I, Roccatello D, Giordana MT. Progressive multifocal leukoencephalopathy during cyclosporine treatment. A case report. Ital J Neurol Sci. 1996;17:363–366
  12. Whiteman ML, Post MJ, Berger JR, Tate LG, Bell MD, Limonte LP. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology. 1993;187:233–240
  13. Happe S, Besselmann M, Matheja P, Rickert CH, Schuierer G, Reichelt D, et al. Cidofovir (vistide) in therapy of progressive multifocal leukoencephalopathy in AIDS. Review of the literature and report of 2 cases. Nervenarzt. 1999;70:935–943
  14. Segarra-Newnham M, Vodolo KM. Use of cidofovir in progressive multifocal leukoencephalopathy. Ann Pharmacother. 2001;35:741–744
  15. Berger JR, Concha M. Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J Neurovirology. 1995;1:5–18
  16. Koralnik IJ. New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol. 2004;17:365–370
  17. Weber T, Weber F, Petry H, Luke W. Immune response in progressive multifocal leukoencephalopathy: an overview. J Neurovirology. 2001;7:311–317
  18. Elphick GF, Querbes W, Jordan JA, Gee GV, Eash S, Manley K, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science. 2004;306:1380–1383
  19. Chowdhury M, Kundu M, Khalili K. GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system. Oncogene. 1993;8:887–892
  20. Koralnik IJ, Boden D, Mai VX, Lord CI, Letvin NL. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology. 1999;52:253–260
  21. Pfister LA, Letvin NL, Koralnik IJ. JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy. J Virol. 2001;75:5672–5676
  22. Yogo Y, Kitamura T, Sugimoto C, Ueki T, Aso Y, Hara K, et al. Isolation of a possible archetypal JC virus DNA sequence from non immunocompromised individuals. J Virol. 1990;64:3139–3143
  23. Kato A, Kitamura T, Takasaka T, Tominaga T, Ishikawa A, Zheng HY, et al. Detection of the archetypal regulatory region of JC virus from the tonsil tissue of patients with tonsillitis and tonsilar hypertrophy. J Neurovirology. 2004;10:244–249
  24. Fedele CG, Polo C, Tenorio A, Niubò J, Ciardi MR, Pérez JL. Analysis of the transcriptional control region of JC polyomavirus in cerebrospinal fluid from HIV-negative patients with progressive multifocal leucoencephalopathy. J Med Virol. 2006;78:1271–1275
  25. Elsner C, Dorries K. Evidence of human polyomavirus BK and JC infection in normal brain tissue. Virology. 1992;191:72–80
  26. Bezrodnik L, Samara R, Krasovec S, Garcia Erro M, Sevlever G. Progressive multifocal leukoencephalopathy in a patient with hypogammaglobulinemia. Clin Infect Dis. 1998;27:181–184
  27. Brooks B, Walker D. Progressive multifocal leukoencephalopathy. Neurol Clin. 1984;2:299–313
  28. Kleinschmidt-DeMasters BK, Tyler KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med. 2005;353:369–374
  29. Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med. 2005;353:375–381
  30. Van Assche G, Van Ranst M, Sciot R, Dubois B, Vermeire S, Noman M, et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med. 2005;353:362–368
  31. Engelhardt B, Briskin MJ. Therapeutic targeting of alpha 4-integrins in chronic inflammatory diseases: tipping the scales of risk towards benefit?. Eur J Immunol. 2005;35:2268–2273
  32. Shitrit D, Lev N, Bar-Gil-Shitrit A, Kramer MR. Progressive multifocal leukoencephalopathy in transplant recipients. Transpl Int. Jan, 2005;17:658–665
  33. Fong IW, Britton CB, Luinstra KE, Toma E, Mahony JB. Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol. 1995;33:484–486
  34. d'Arminio Monforte A, Cinque P, Vago L, Rocca A, Castagna A, Gervasoni C, et al. A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients. J Neurol. 1997;244:35–39
  35. Bogdanovic G, Priftakis P, Hammarin AL, et al. Detection of JC virus in cerebrospinal fluid (CSF) samples from patients with progressive multifocal leukoencephalopathy but not in CSF samples from patients with herpes simplex encephalitis, enteroviral meningitis, or multiple sclerosis. J Clin Microbiol. 1998;36:1137–1138
  36. Weber T, Turner RW, Frye S, Ruf B, Haas J, Schielke E, et al. Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J Infect Dis. 1994;169:1138–1141
  37. Mossakowski M, Zelman I. Pathomorphological variations of the AIDS-associated progressive multifocalleukoencephalopathy. Folia Neuropathol. 2000;38:91–100
  38. Koralnik I. Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name?. Ann Neurol. 2006;60:162–173
  39. Post M, Yiannoutsos C, Simpson D, Booss J, Clifford D, Cohen B, et al. Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team. AJNR Am J Neuroradiol. 1999;20:1896–1906
  40. Berger JR, Levy RM, Flomenhoft D, Dobbs M. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol. 1998;44:341–349
  41. Kaye BR, Neuwelt CM, London SS, DeArmond SJ. Central nervous system systemic lupus erythematosus mimicking progressive multifocal leucoencephalopathy. Ann Rheum Dis. 1992;51:1152–1156
  42. Antinori A, Cingolani A, Lorenzini P, Giancola ML, Uccella I, Bossolasco S, et al. Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J Neurovirology. 2003;9(Suppl 1):47–53
  43. Berenguer J, Miralles P, Arrizabalaga J, et al. Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy. Clin Infect Dis. 2003;36:1047–1052
  44. Marra CM, Rajicic N, Barker DE, Cohen BA, Clifford D, Donovan Post MJ, et al. A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. Aids. 2002;16:1791–1797
  45. Gasnault J, Kousignian P, Kahraman M, Rahoiljaon J, Matheron S, Delfraissy JF, et al. Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring. J Neurovirology. 2001;7:375–381
  46. Williams JW, Javaid B, Kadambi PV, Gillen D, Harland R, Thistlewaite JR, et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med. 2005;352:1157–1158
  47. Farasati NA, Shapiro R, Vats A, Randhawa P. Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation. 2005;79:116–118
  48. Warnatz K, Peter HH, Schumacher M, Wiese L, Prasse A, Petschner F, et al. Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature. Ann Rheum Dis. 2003;62:50–57
  49. Crowder CD, Gyure KA, Drachenberg CB, Werner J, Morales RE, Hirsch HH, et al. Successful outcome of progressive multifocal leukoencephalopathy in a renal transplant patient. Am J Transplant. 2005;5:1151–1158

PII: S0953-6205(08)00207-0

doi: 10.1016/j.ejim.2008.07.032

European Journal of Internal Medicine
Volume 20, Issue 3 , Pages 261-267 , May 2009

Article Tools

* Image Usage & Resolution